Search

everythinglearnresearchcommunity

for

Search:↓

Twisting hair weakens it, but strength can be recovered at low twist levels.

Women with PCOS have a higher risk of diabetes and heart problems, especially when they get older.

Creatine monohydrate is safe and effective for muscle recovery and performance, especially for those with low creatine levels.

Future hormone therapy trials should match the diverse needs and priorities of the gender-diverse community.

The document suggests medicine should integrate biological and cultural factors and focus on holistic, equitable care.

Most drugs fail to reach the market, but understanding their properties and using strategies like early toxicity tests and drug repurposing can help advance their development.

Many skin patients have mental health issues, but few dermatologists are well-versed in treating these conditions.

New guidelines using video aim to ensure honest reporting of hair loss treatments.

Dermatologists are essential in helping transgender and gender diverse patients with skin and hair issues related to gender affirmation and hormone therapy.

The document concludes that managing non-classical congenital adrenal hyperplasia in females requires personalized treatment, genetic counseling, and a team of specialists.

The document concludes that more local research on African skin and hair is needed despite increased scientific output from Sub-Saharan Africa.

The BJUI supports clinical trials as key for unbiased medical evidence and works to enhance their design, reporting, and discussion.

Hair loss can cause stress and mental health issues, so treatments should address both the physical and psychological aspects, involving a team of dermatologists, psychologists, and hair specialists.

Some skin medication can rarely cause or worsen mental health issues; knowing this is important because mental health problems are increasing worldwide.

The document concludes that facial feminization surgery improves psychological well-being and social acceptance for transgender individuals.

Genetic mutations can affect female sexual development, requiring personalized medical care.

When treating older patients with both heart valve disease and heart muscle disease, doctors should create personalized treatment plans that address both conditions.

The conclusion is that off-label drug use can lead to important medical discoveries and improve patient care.

The article emphasizes the need for proper training and ethical practice in hair transplantation to prevent poor outcomes and psychological harm to patients.

Educators who survived COVID-19 faced physical, psychological, and social challenges but overcame them with resilience and support, highlighting the need for schools to provide better health and psychological care.

The document concludes that treatments for hair loss in transgender and gender-diverse individuals include topical solutions, oral medications, laser therapy, and hair restoration procedures, with progress assessed after 6-12 months.

Glucocorticoid treatment in lupus can cause oral lesions, which need early diagnosis and comprehensive care.

IVL3001 is safe, effective, and better than oral finasteride for treating hair loss.

Testosterone therapy helps boys with hormone deficiencies develop normal male characteristics and grow properly.

Patients with rheumatoid arthritis using tofacitinib had more serious side effects than those with alopecia areata.

Professor Edward Carmeliet was a leading figure in cardiac electrophysiology research.

Helmets used in acupuncture and light therapy can affect brain blood flow, hair growth, and may improve brain diseases and cognitive functions.

Surgical hair restoration involves moving hair from a non-balding area to a balding area, with the transplanted hair not subject to male pattern baldness. Medications can slow hair loss and regrow some hair, but successful treatment needs careful planning, skill, and ethical responsibility due to progressive hair loss and limited donor hair.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

A substance called prostaglandin D2 is linked to stopping hair growth in men with common baldness.